Genetic associations with suicide attempt severity and genetic overlap with major depression

Translational Psychiatry

Volumn 9, Issue 1, 2019, Pages

  Levey, Daniel F ^a,b   Polimanti, Renato ^a,b   Cheng, Zhongshan ^a,b   Zhou, Hang ^a,b   Nuñez, Yaira Z ^a,b   Jain, Sonia ^c   He, Feng ^c   Sun, Xiaoying ^c   Ursano, Robert J ^d   Kessler, Ronald C ^e   Smoller, Jordan W ^f,g   Stein, Murray B ^c,h   Kranzler, Henry R ^i,j   Gelernter, Joel ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^h VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR LIKE 2; FUMARYLACETOACETASE; LACTATE DEHYDROGENASE B; NMDA RECEPTOR REGULATED 2; PIGGYBAC TRANSPOSABLE ELEMENT DERIVED 5; PLECKSTRIN HOMOLOGY LIKE DOMAIN FAMILY B MEMBER 2; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; ARTICLE; CHROMOSOME 12; CHROMOSOME 15; CHROMOSOME 18; CIRCADIAN RHYTHM; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DEPENDENCE; ENERGY YIELD; EUROPEAN AMERICAN; FEMALE; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENOME-WIDE ASSOCIATION STUDY; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDE ATTEMPT; CAUCASIAN; CLINICAL TRIAL; GENETIC PREDISPOSITION; GENETICS; MULTICENTER STUDY; MULTIFACTORIAL INHERITANCE; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; UNITED STATES;

ADULT; AFRICAN AMERICANS; DEPRESSIVE DISORDER, MAJOR; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LINEAR MODELS; MALE; MULTIFACTORIAL INHERITANCE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; SUICIDE, ATTEMPTED; UNITED STATES;

EID: 85060131181     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/s41398-018-0340-2     Document Type: Article

References (50)

1. Preti, A. Animal model and neurobiology of suicide. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 818–830 (2011).
2. Mullins, N. et al. Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 165B, 428–437 (2014).
3. Sokolowski, M., Wasserman, J. & Wasserman, D. Genome-wide association studies of suicidal behaviors: a review. Eur. Neuropsychopharmacol. 24, 1567–1577 (2014).
4. Mirkovic, B. et al. Genetic association studies of suicidal behavior: a review of the past 10 years, progress, limitations, and future directions. Front. Psychiatry 7, 158 (2016).
5. Willour, V. L. et al. A genome-wide association study of attempted suicide. Mol. Psychiatry 17, 433–444 (2012).
6. Stein, M. B. et al. Genomewide association studies of suicide attempts in US soldiers. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 174, 786–797 (2017).
7. Erlangsen A. et al. Genetics of suicide attempts in individuals with and without mental disorders: a population-based genome-wide association study. Mol. Psychiatry (2018). 10.1038/s41380-018-0218-y.
8. Schosser, A. et al. Genomewide association scan of suicidal thoughts and behaviour in major depression. PLoS ONE 6, e20690 (2011).
9. van der Sluis, S., Posthuma, D., Nivard, M. G., Verhage, M. & Dolan, C. V. Power in GWAS: lifting the curse of the clinical cut-off. Mol. Psychiatry 18, 2–3 (2013).
10. Gelernter, J. et al. Genome-wide association study of alcohol dependence:significant findings in African- and European-Americans including novel risk loci. Mol. Psychiatry 19, 41–49 (2014).
11. Gelernter, J. et al. Genome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways. Biol. Psychiatry 76, 66–74 (2014).
12. Gelernter, J. et al. Genome-wide association study of cocaine dependence and related traits: FAM53B identified as a risk gene. Mol. Psychiatry 19, 717–723 (2014).
13. Zhou, H. et al. Genetic risk variants associated with comorbid alcohol dependence and major depression. JAMA Psychiatry 74, 1234–1241 (2017).
14. Pierucci-Lagha, A. et al. Diagnostic reliability of the semi-structured assessment for drug dependence and alcoholism (SSADDA). Drug Alcohol. Depend. 80, 303–312 (2005).
15. Asberg, M., Traskman, L. & Thoren, P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch. Gen. Psychiatry 33, 1193–1197 (1976).
16. Gelernter, J. et al. Genomewide linkage scan for cocaine dependence and related traits: significant linkages for a cocaine-related trait and cocaine-induced paranoia. Am. J. Med. Genet. Part B, Neuropsychiatr. Genet. 136B, 45–52 (2005).
17. Gelernter, J. et al. Genomewide linkage scan for opioid dependence and related traits. Am. J. Hum. Genet. 78, 759–769 (2006).
18. Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).
19. Zhou, X. & Stephens, M. Genome-wide efficient mixed-model analysis for association studies. Nat. Genet. 44, 821–824 (2012).
20. Euesden, J., Lewis, C. M. & O’Reilly, P. F. PRSice: polygenic risk score software. Bioinformatics 31, 1466–1468 (2015).
21. Wray, N. R. et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat. Genet. 50, 668–681 (2018).
22. Watanabe, K., Taskesen, E., van Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1826 (2017).
23. Sherva, R. et al. Genome-wide association study of cannabis dependence severity, novel risk variants, and shared genetic risks. JAMA Psychiatry 73, 472–480 (2016).
24. Owens, D., Horrocks, J. & House, A. Fatal and non-fatal repetition of self-harm. Syst. Rev. Br. J. Psychiatry 181, 193–199 (2002).
25. Suominen, K. et al. Completed suicide after a suicide attempt: a 37-year follow-up study. Am. J. Psychiatry 161, 562–563 (2004).
26. Carroll, R., Metcalfe, C. & Gunnell, D. Hospital presenting self-harm and risk of fatal and non-fatal repetition: systematic review and meta-analysis. PLoS ONE 9, e89944 (2014).
27. Bostwick, J. M., Pabbati, C., Geske, J. R. & McKean, A. J. Suicide attempt as a risk factor for completed suicide: even more lethal than we knew. Am. J. Psychiatry 173, 1094–1100 (2016).
28. McKean, A. J. S., Pabbati, C. P., Geske, J. R. & Bostwick, J. M. Rethinking lethality in youth suicide attempts: first suicide attempt outcomes in youth ages 10 to 24. J. Am. Acad. Child Adolesc. Psychiatry 57, 786–791 (2018).
29. Beck, A. T., Beck, R. & Kovacs, M. Classification of suicidal behaviors: I. Quantifying intent and medical lethality. Am. J. Psychiatry 132, 285–287 (1975).
30. Beck, A. T., Weissman, A., Lester, D. & Trexler, L. Classification of suicidal behaviors. II. Dimens. suicidal Intent. Arch. Gen. Psychiatry 33, 835–837 (1976).
31. Posner, K. et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am. J. Psychiatry 168, 1266–1277 (2011).
32. Bernanke, J. A., Stanley, B. H. & Oquendo, M. A. Toward fine-grained phenotyping of suicidal behavior: the role of suicidal subtypes. Mol. Psychiatry 22, 1080–1081 (2017).
33. Niculescu, A. B. et al. Precision medicine for suicidality: from universality to subtypes and personalization. Mol. Psychiatry 22, 1250–1273 (2017).
34. Herberth, M. et al. Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients. Mol. Psychiatry 16, 848–859 (2011).
35. Levey, D. F. et al. Towards understanding and predicting suicidality in women: biomarkers and clinical risk assessment. Mol. Psychiatry 21, 768–785 (2016).
36. Niculescu, A. B. et al. Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach. Mol. Psychiatry 20, 1266–1285 (2015).
37. Jeremian, R. et al. Investigation of correlations between DNA methylation, suicidal behavior and aging. Bipolar Disord. 19, 32–40 (2017).
38. Cittaro, D. et al. Histone modifications in a mouse model of early adversities and panic disorder: role for asic1 and neurodevelopmental genes. Sci. Rep. 6, 25131 (2016).
39. Goodwin, R. D. & Roy-Byrne, P. Panic and suicidal ideation and suicide attempts: results from the National Comorbidity Survey. Depress Anxiety 23, 124–132 (2006).
40. Shi, J. et al. Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 147B, 1047–1055 (2008).
41. Parsons, M. J. et al. Polymorphisms in the circadian expressed genes PER3 and ARNTL2 are associated with diurnal preference and GNbeta3 with sleep measures. J. Sleep. Res. 23, 595–604 (2014).
42. Lv, B. et al. Comprehensive analysis and experimental verification of LINC01314 as a tumor suppressor in hepatoblastoma. Biomed. Pharmacother. 98, 783–792 (2018).
43. Sugiura, N., Patel, R. G. & Corriveau, R. A. N-methyl-D-aspartate receptors regulate a group of transiently expressed genes in the developing brain. J. Biol. Chem. 276, 14257–14263 (2001).
44. Smith, E. R. et al. The little elongation complex regulates small nuclear RNA transcription. Mol. Cell 44, 954–965 (2011).
45. Malone, K. M., Haas, G. L., Sweeney, J. A. & Mann, J. J. Major depression and the risk of attempted suicide. J. Affect Disord. 34, 173–185 (1995).
46. Neeleman, J. A continuum of premature death. Meta-analysis of competing mortality in the psychosocially vulnerable. Int J. Epidemiol. 30, 154–162 (2001).
47. Chesney, E., Goodwin, G. M. & Fazel, S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry 13, 153–160 (2014).
48. Dwivedi, Y. et al. Neurotrophin receptor activation and expression in human postmortem brain: effect of suicide. Biol. Psychiatry 65, 319–328 (2009).
49. Le-Niculescu, H. et al. Discovery and validation of blood biomarkers for suicidality. Mol. Psychiatry 18, 1249–1264 (2013).
50. Harris, E. C. & Barraclough, B. Suicide as an outcome for mental disorders. A meta-analysis. Br. J. Psychiatry 170, 205–228 (1997).